Clinical Trial

Body Awareness Therapy and Biomarkers in Fibromyalgia

Study acronym: BATBF
Recruiting
View on ClinicalTrials.gov →
Summary
A randomized trial of Basic Body Awareness Therapy (BBAT) is applied in fibromyalgia patients as compared with a control intervention consisting of stretching. Sessions of BBAT lasted 90 min each and took place twice a week form 12 weeks. The primary end point is a change in the biomarkers and neurotransmitters and the Fibromyalgia Impact Questionnaire and the secondary end points include Visual Analog Scale, State Trait Anxiety inventory, Beck Depression Inventory. All assessments will be repeated at post treatment, 12 and 24 weeks and 1 year follow-up.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-09-21; most recent amendment 2025-05-05.
Status change: Not Yet Recruiting → Recruiting 2024-05-08
Trial Details
NCT Number NCT05555394
Lead Sponsor Universitat de Lleida
Collaborators: Consorci Sanitari de l'Anoia
Conditions Fibromyalgia
Enrollment 110 participants
Start Date 2024-05-08
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-08